How nasal sprays or pills can keep COVID-19 at bay?
So far, ImmunityBio is the only company authorized by the FDA to enter phase 1 clinical trials with its oral COVID-19 vaccines.
For pills: The ImmunityBio vaccine uses a new method of protection compared to the injectable vaccines we currently have. This oral vaccine can target the stable inner spike protein, as well as the outer spike protein, which is more prone to mutations.
This process can activate T cells and memory B cells which can fight the SARS-CoV-2 virus.
For nasal spray: This method, currently developed by the Altimmune company, helps the body start an autoimmune response as soon as the virus enters the system, thus causing mucosal immunity right in the nostrils. The vaccine is meant to trigger antibody and T-cell immune responses inside the nasal cavity.
By comparison, the injectable vaccines (Pfizer-BioNTech, Moderna, Johnson & Johnson) trigger an immune response inside our body to start producing antibodies which can fight off the virus.
The World Health Organization said it could have 'severe consequences.' The U.S. restricted travel in… READ ON
Hypertension, also known as high blood pressure, is the most preventable risk factor for heart… READ ON
The Centers for Disease Control and Prevention has decided and gave a final signoff Friday… READ ON
Covid Nails The general signs of Covid-19 are fever, cough, fatigue, and that famous loss… READ ON
After receiving a wincingly high credit card bill, you start to wonder what you did… READ ON
If we're talking about staying hydrated, flushing out toxins, and keeping good tonus, water is… READ ON